ModuLink Inc.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 30, 2026, ModuLink Inc. (the “Company” or “ModuLink”) announced that the Board of Directors of the Company (the “Board”) approved the appointment of Dr. Wah Shing Lam ("Dr. Lam"), age 31, as an Executive Director of the Company, effective July 1, 2026. Dr. Lam currently serves as the Company's Chief Technology Officer and will continue in that role following his appointment to the Board. As Chief Technology Officer, Dr. Lam is responsible for the Company's technology strategy, research and development initiatives, and the integration of artificial intelligence, robotics and automation technologies across the Company's business. Dr. Lam has contributed to the strategic and technological development of the ModuLink group of companies. In approving the appointment, the Board considered Dr. Lam's experience, expertise and leadership, as well as his contributions to the Company's development and his existing executive role. Additional biographical information regarding Dr. Lam is set forth below. Biography Dr. Lam is a biomedical engineer and technology entrepreneur with a PhD in Biomedical Engineering and a first-class honours degree in Mechatronic Engineering from City University of Hong Kong. His academic work centres on clinically graded medical micro-robotic systems for cartilage regeneration in degenerative knee joints, complemented by early research in humanoid robotics and AI as a visiting researcher at the Institute of Automation, Chinese Academy of Sciences. He is the Founder and Chief Executive Officer of ASA Robotics Limited, where he led the development of the HORIZON patient transfer robot, the LUNA fall-prevention system, and the RAMP robot analytics and management platform, serving hospitals and enterprises with AI-driven automation solutions. Dr. Lam currently serves as the Chief Technology Officer of ModuLink Inc., where he is responsible for leading the Group's technology strategy and innovation across its subsidiaries and business units. In this role, he oversees group-wide research and development initiatives, drives the integration of artificial intelligence, robotics and automation technologies across the Company's portfolio, leads digital transformation initiatives to enhance operational efficiency, develops strategic technology partnerships and investments, and builds and mentors the Company's global engineering and innovation teams. In addition to his role with the Company, he is currently appointed as MRI Associate Head at the Hong Kong Centre for Cerebro-Cardiovascular Health Engineering, where he focuses on commercializing preventive healthcare technologies and solutions. From 2020 to 2024, Dr Lam served as a commission member of the Youth Development Commission of the HKSAR Government, contributing to youth policy, strategy and public engagement.